The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum

Psychological Medicine

Volumn 48, Issue 2, 2018, Pages 229-244

  Guloksuz, S ^a,b   Van Os, J ^a,c,d  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Classification; clinical staging; diagnosis; DSM; outcome; psychosis spectrum disorder

Indexed keywords

CLASSIFICATION; HUMAN; PSYCHOSIS; SCHIZOPHRENIA;

HUMANS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 85021968418     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291717001775     Document Type: Review

References (139)

1. Abel KM, Drake R, Goldstein JM (2010). Sex differences in schizophrenia. International Review of Psychiatry 22, 417-428.
2. Aleman A, Kahn RS, Selten JP (2003). Sex differences in the risk of schizophrenia: evidence from meta-analysis. Archives of General Psychiatry 60, 565-571.
3. Allardyce J, Morrison G, Van Os J, Kelly J, Murray RM, McCreadie RG (2000). Schizophrenia is not disappearing in south-west Scotland. British Journal of Psychiatry 177, 38-41.
4. Allardyce J, van Os J (2010). The natural history of the course and outcome of schizophrenia. In Advances in Schizophrenia Research 2009 (ed. W. F. Gattaz, G. Busatto), pp. 51-65. Springer New York: New York, NY.
5. American Psychiatric Association (2013). DSM-5 Fact Sheets. (https://www.psychiatry.org/psychiatrists/practice/dsm/ educational-resources/dsm-5-fact-sheets). Accessed 1 January 2017.
6. Andreasen NC (1989). The American concept of schizophrenia. Schizophrenia Bulletin 15, 519-531.
7. Beauchamp G, Gagnon A (2004). Influence of diagnostic classification on gender ratio in schizophrenia-A meta-analysis of youths hospitalized for psychosis. Social Psychiatry and Psychiatric Epidemiology 39, 1017-1022.
8. Bentall RP, Beck AT (2004). Madness Explained: Psychosis and Human Nature. Penguin Books: London.
9. Bentall RP, Jackson HF, Pilgrim D (1988). Abandoning the concept of 'schizophrenia': some implications of validity arguments for psychological research into psychotic phenomena. British Journal of Clinical Psychology 27(Pt 4), 303-324.
10. Bora E, Yucel M, Pantelis C (2009). Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study. British Journal of Psychiatry 195, 475-482.
11. Boteva K, Lieberman J (2003). Reconsidering the classification of schizophrenia and manic depressive illness-A critical analysis and new conceptual model. World Journal of Biological Psychiatry 4, 81-92.
12. Brockington IF (1992). Schizophrenia: yesterday's concept. European Psychiatry 7, 203-207.
13. Bromet EJ, Naz B, Fochtmann LJ, Carlson GA, Tanenberg-Karant M (2005). Long-term diagnostic stability and outcome in recent first-episode cohort studies of schizophrenia. Schizophrenia Bulletin 31, 639-649.
14. Carpenter WT (2017). Fifty years: do over or move forward. Schizophrenia Bulletin 43, 257-259.
15. Carpenter Jr. WT, Heinrichs DW, Wagman AM (1988). Deficit and nondeficit forms of schizophrenia: the concept. American Journal of Psychiatry 145, 578-583.
16. Carpenter Jr. WT, Strauss JS, Bartko JJ (1973). Flexible system for the diagnosis of schizophrenia: report from the WHO International Pilot Study of Schizophrenia. Science 182, 1275-1278.
17. Castle DJ, Wessely S, Murray RM (1993). Sex and schizophrenia: effects of diagnostic stringency, and associations with and premorbid variables. British Journal of Psychiatry 162, 658-664.
18. Chase R (2008). Schizophrenia is a disease, so electrons aren't at risk. Nature 451, 127.
19. Cohen P, Cohen J (1984). The clinician's illusion. Archives of General Psychiatry 41, 1178-1182.
20. Confavreux C, Vukusic S (2006). Natural history of multiple sclerosis: a unifying concept. Brain 129, 606-616.
21. Cougnard A, Marcelis M, Myin-Germeys I, De Graaf R, Vollebergh W, Krabbendam L, Lieb R, Wittchen HU, Henquet C, Spauwen J, Van Os J (2007). Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness-persistence model. Psychological Medicine 37, 513-527.
22. Cuthbert BN, Insel TR (2010). Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria project. Schizophrenia Bulletin 36, 1061-1062.
23. Demjaha A, Morgan K, Morgan C, Landau S, Dean K, Reichenberg A, Sham P, Fearon P, Hutchinson G, Jones PB, Murray RM, Dazzan P (2009). Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11? Psychological Medicine 39, 1943-1955.
24. Dominguez MD, Saka MC, Lieb R, Wittchen HU, van Os J (2010). Early expression of negative/disorganized symptoms predicting psychotic experiences and subsequent clinical psychosis: a 10-year study. American Journal of Psychiatry 167, 1075-1082.
25. Dominguez MD,Wichers M, Lieb R, Wittchen HU, van Os J (2011). Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study. Schizophrenia Bulletin 37, 84-93.
26. Dutta R, Greene T, Addington J, McKenzie K, Phillips M, Murray RM (2007). Biological, life course, and cross-cultural studies all point toward the value of dimensional and developmental ratings in the classification of psychosis. Schizophrenia Bulletin 33, 868-876.
27. Fusar-Poli P, Yung AR, McGorry P, van Os J (2014). Lessons learned from the psychosis high-risk state: towards a general staging model of prodromal intervention. Psychological Medicine 44, 17-24.
28. Geekie J, Read J (2009). Making Sense of Madness: Contesting the Meaning of Schizophrenia. Routledge: New York, NY.
29. George B, Klijn A (2013). A modern name for schizophrenia (PSS) would diminish self-stigma. Psychological Medicine 43, 1555-1557.
30. Goodkind M, Eickhoff SB, Oathes DJ, Jiang Y, Chang A, Jones-Hagata LB, Ortega BN, Zaiko YV, Roach EL, Korgaonkar MS, Grieve SM, Galatzer-Levy I, Fox PT, Etkin A (2015). Identification of a common neurobiological substrate for mental illness. JAMA Psychiatry 72, 305-315.
31. Gottesman II, Shields J (1967). A polygenic theory of schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 58, 199-205.
32. Guloksuz S, van Nierop M, Lieb R, van Winkel R, Wittchen HU, van Os J (2015). Evidence that the presence of psychosis in non-psychotic disorder is environmentdependent and mediated by severity of non-psychotic psychopathology. Psychological Medicine 45, 2389-2401.
33. Hanssen M, Bak M, Bijl R, Vollebergh W, van Os J (2005). The incidence and outcome of subclinical psychotic experiences in the general population. British Journal of Clinical Psychology 44, 181-191.
34. Harding CM, Zubin J, Strauss JS (1987). Chronicity in schizophrenia: fact, partial fact, or artifact? Hospital and Community Psychiatry 38, 477-486.
35. Heckers S, BarchDM,Bustillo J, GaebelW, Gur R, Malaspina D, Owen MJ, Schultz S, Tandon R, Tsuang M, Van Os J, CarpenterW(2013). Structure of the psychotic disorders classification in DSM-5. Schizophrenia Research 150, 11-14.
36. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G (1994). One hundred years of schizophrenia: a meta-analysis of the outcome literature. American Journal of Psychiatry 151, 1409-1416.
37. Henderson S, Malhi GS (2014). Swan song for schizophrenia? Australian and New Zealand Journal of Psychiatry 48, 302-305.
38. Henquet C, Krabbendam L, Spauwen J, Kaplan C, Lieb R, Wittchen H-U, van Os J (2004). Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 330, 11.
39. Hill SK, Reilly JL, Keefe RS, Gold JM, Bishop JR, Gershon ES, Tamminga CA, Pearlson GD, Keshavan MS, Sweeney JA (2013). Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. American Journal of Psychiatry 170, 1275-1284.
40. Honings S, Drukker M, Groen R, van Os J (2016a). Psychotic experiences and risk of self-injurious behaviour in the general population: a systematic review and meta-analysis. Psychological Medicine 46, 237-251.
41. Honings S, Drukker M, van Nierop M, van Winkel R, Wittchen HU, Lieb R, Ten Have M, de Graaf R, van Dorsselaer S, van Os J (2016b). Psychotic experiences and incident suicidal ideation and behaviour: disentangling the longitudinal associations from connected psychopathology. Psychiatry Research 245, 267-275.
42. Ioannidis JP (2005). Why most published research findings are false. PLoS Medicine 2, e124.
43. Isvoranu AM, Borsboom D, van Os J, Guloksuz S (2016). A network approach to environmental impact in psychotic disorder: brief theoretical framework. Schizophrenia Bulletin 42, 870-873.
44. Ivleva EI, Bidesi AS, KeshavanMS, Pearlson GD, Meda SA, DodigD,MoatesAF,LuH,FrancisAN,TandonN,Schretlen DJ, Sweeney JA, Clementz BA, Tamminga CA (2013). Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). American Journal of Psychiatry 170, 1285-1296.
45. Jaaskelainen E, Juola P, Hirvonen N, McGrath JJ, Saha S, Isohanni M, Veijola J, Miettunen J (2013). A systematic review and meta-analysis of recovery in schizophrenia. Schizophrenia Bulletin 39, 1296-1306.
46. Jablensky A (2010). The diagnostic concept of schizophrenia: its history, evolution, and future prospects. Dialogues in Clinical Neuroscience 12, 271-287.
47. Joseph AJ, Tandon N, Yang LH, Duckworth K, Torous J, Seidman LJ, Keshavan MS (2015). #Schizophrenia: use and misuse on Twitter. Schizophrenia Research 165, 111-115.
48. Kapur S, Phillips AG, Insel TR (2012). Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Molecular Psychiatry 17, 1174-1179.
49. Kaymaz N, Drukker M, Lieb R, Wittchen HU, Werbeloff N, Weiser M, Lataster T, van Os J (2012). Do subthreshold psychotic experiences predict clinical outcomes in unselected non-help-seeking population-based samples? A systematic review and meta-analysis, enriched with new results. Psychological Medicine 42, 2239-2253.
50. Kaymaz N, van Os J, de Graaf R, Ten Have M, Nolen W, Krabbendam L (2007). The impact of subclinical psychosis on the transition from subclinicial mania to bipolar disorder. Journal of Affective Disorders 98, 55-64.
51. Kelleher I, Keeley H, Corcoran P, Lynch F, Fitzpatrick C, Devlin N,Molloy C, Roddy S, ClarkeMC, Harley M, Arseneault L,WassermanC,CarliV, SarchiaponeM,Hoven C, Wasserman D, CannonM(2012). Clinicopathological significance of psychotic experiences in non-psychotic young people: Evidence from four population-based studies. British Journal of Psychiatry 201, 26-32.
52. Kendell R, Jablensky A (2003). Distinguishing between the validity and utility of psychiatric diagnoses. American Journal of Psychiatry 160, 4-12.
53. Kendler KS (2016a). Phenomenology of schizophrenia and the representativeness of modern diagnostic criteria. JAMA Psychiatry 73, 1082-1092.
54. Kendler KS (2016b). The transformation of American psychiatric nosology at the dawn of the twentieth century. Molecular Psychiatry 21, 152-158.
55. Keshavan MS, Nasrallah HA, Tandon R (2011). Schizophrenia, 'Just the Facts' 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse. Schizophrenia Research 127, 3-13.
56. Kirkpatrick B, Buchanan RW, Ross DE, Carpenter Jr. WT (2001). A separate disease within the syndrome of schizophrenia. Archives of General Psychiatry 58, 165-171.
57. Kirkpatrick B, Fenton WS, Carpenter Jr. WT, Marder SR (2006). The NIMH-MATRICS consensus statement on negative symptoms. Schizophrenia Bulletin 32, 214-219.
58. Kirkpatrick B, Galderisi S (2008). Deficit schizophrenia: an update. World Psychiatry 7, 143-147.
59. Koike S, Yamaguchi S, Ojio Y, Ohta K, Ando S (2016). Effect of name change of schizophrenia on mass media between 1985 and 2013 in Japan: a text data mining analysis. Schizophrenia Bulletin 42, 552-559.
60. Krabbendam L, Myin-Germeys I, De Graaf R, Vollebergh W, Nolen WA, Iedema J, Van Os J (2004). Dimensions of depression, mania and psychosis in the general population. Psychological Medicine 34, 1177-1186.
61. Kraemer HC (2007). DSM categories and dimensions in clinical and research contexts. International Journal of Methods in Psychiatric Research 16(Suppl 1), S8-S15.
62. Kraepelin E (1992). Die Erscheinungsformen des Irreseins: (the manifestations of insanity). History of Psychiatry 3, 509-529.
63. Lasalvia A, Penta E, Sartorius N, Henderson S (2015). Should the label 'schizophrenia' be abandoned? Schizophrenia Research 162, 276-284.
64. Leamy M, Bird V, Le Boutillier C, Williams J, Slade M (2011). Conceptual framework for personal recovery in mental health: systematic review and narrative synthesis. British Journal of Psychiatry 199, 445-452.
65. Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A, Goddard ME, Witte JS, Absher D, Agartz I, Akil H, Amin F, Andreassen OA, Anjorin A, Anney R, Anttila V, Arking DE, Asherson P, Azevedo MH, Backlund L, Badner JA, Bailey AJ, Banaschewski T, Barchas JD, Barnes MR, Barrett TB, Bass N, Battaglia A, Bauer M, Bayes M, Bellivier F, Bergen SE, Berrettini W, Betancur C, Bettecken T, Biederman J, Binder EB, Black DW, Blackwood DH, Bloss CS, BoehnkeM, Boomsma DI, Breen G, Breuer R, Bruggeman R, Cormican P, Buccola NG, Buitelaar JK, Bunney WE, Buxbaum JD, Byerley WF, Byrne EM, Caesar S, Cahn W, Cantor RM, Casas M, Chakravarti A, Chambert K, Choudhury K, Cichon S, Cloninger CR, Collier DA, Cook EH, Coon H, Cormand B, Corvin A, Coryell WH, Craig DW, Craig IW, Crosbie J, Cuccaro ML, Curtis D, Czamara D, Datta S, Dawson G, Day R, De Geus EJ, Degenhardt F, Djurovic S, Donohoe GJ, Doyle AE, Duan J, Dudbridge F, Duketis E, Ebstein RP, Edenberg HJ, Elia J, Ennis S, Etain B, Fanous A, Farmer AE, Ferrier IN, Flickinger M, Fombonne E, Foroud T, Frank J, Franke B, Fraser C, Freedman R, Freimer NB, Freitag CM, Friedl M, Frisen L, Gallagher L, Gejman PV, Georgieva L, Gershon ES, Geschwind DH, Giegling I, Gill M, Gordon SD, Gordon-Smith K, Green EK, Greenwood TA, Grice DE, Gross M, Grozeva D, Guan W, Gurling H, De Haan L, Haines JL, Hakonarson H, Hallmayer J, Hamilton SP, Hamshere ML, Hansen TF, Hartmann AM, Hautzinger M, Heath AC, Henders AK, Herms S, Hickie IB, Hipolito M, Hoefels S, Holmans PA, Holsboer F, Hoogendijk WJ, Hottenga JJ, Hultman CM, Hus V, Ingason A, Ising M, Jamain S, Jones EG, Jones I, Jones L, Tzeng JY, Kahler AK, Kahn RS, Kandaswamy R, Keller MC, Kennedy JL, Kenny E, Kent L, Kim Y, Kirov GK, Klauck SM, Klei L, Knowles JA, Kohli MA, Koller DL, Konte B, Korszun A, Krabbendam L, Krasucki R, Kuntsi J, Kwan P, Landen M, Langstrom N, Lathrop M, Lawrence J, Lawson WB, Leboyer M, Ledbetter DH, Lee PH, Lencz T, Lesch KP, Levinson DF, Lewis CM, Li J, Lichtenstein P, Lieberman JA, Lin DY, Linszen DH, Liu C, Lohoff FW, Loo SK, Lord C, Lowe JK, Lucae S, MacIntyre DJ, Madden PA, Maestrini E, Magnusson PK, Mahon PB, Maier W, Malhotra AK, Mane SM, Martin CL, Martin NG, Mattheisen M, Matthews K, Mattingsdal M, McCarroll SA, McGhee KA, McGough JJ, McGrath PJ, McGuffin P, McInnis MG, McIntosh A, McKinney R, McLean AW, McMahon FJ, McMahon WM, McQuillin A, Medeiros H, Medland SE, Meier S, Melle I, Meng F, Meyer J, Middeldorp CM, Middleton L, Milanova V, Miranda A, Monaco AP, Montgomery GW, Moran JL, Moreno-De-Luca D, Morken G, Morris DW, Morrow EM, Moskvina V, Muglia P, Muhleisen TW, Muir WJ, Muller-Myhsok B, Murtha M, Myers RM, Myin-Germeys I, Neale MC, Nelson SF, Nievergelt CM, Nikolov I, Nimgaonkar V, Nolen WA, Nothen MM, Nurnberger JI, Nwulia EA, Nyholt DR, O'Dushlaine C, Oades RD, Olincy A, Oliveira G, Olsen L, Ophoff RA, Osby U, Owen MJ, Palotie A, Parr JR, Paterson AD, Pato CN, Pato MT, Penninx BW, Pergadia ML, Pericak-Vance MA, Pickard BS, Pimm J, Piven J, Posthuma D, Potash JB, Poustka F, Propping P, Puri V, Quested DJ, Quinn EM, Ramos-Quiroga JA, Rasmussen HB, Raychaudhuri S, Rehnstrom K, Reif A, Ribases M, Rice JP, Rietschel M, Roeder K, Roeyers H, Rossin L, Rothenberger A, Rouleau G, Ruderfer D, Rujescu D, Sanders AR, Sanders SJ, Santangelo SL, Sergeant JA, Schachar R, Schalling M, Schatzberg AF, Scheftner WA, Schellenberg GD, Scherer SW, Schork NJ, Schulze TG, Schumacher J, Schwarz M, Scolnick E, Scott LJ, Shi J, Shilling PD, Shyn SI, Silverman JM, Slager SL, Smalley SL, Smit JH, Smith EN, Sonuga-Barke EJ, St Clair D, State M, Steffens M, Steinhausen HC, Strauss JS, Strohmaier J, Stroup TS, Sutcliffe JS, Szatmari P, Szelinger S, Thirumalai S, Thompson RC, Todorov AA, Tozzi F, Treutlein J, Uhr M, van den Oord EJ, Van Grootheest G, Van Os J, Vicente AM, Vieland VJ, Vincent JB, Visscher PM, Walsh CA, Wassink TH, Watson SJ, Weissman MM, Werge T, Wienker TF, Wijsman EM, Willemsen G, Williams N, Willsey AJ, Witt SH, XuW, Young AH, Yu TW, Zammit S, Zandi PP, Zhang P, Zitman FG, Zollner S, Devlin B, Kelsoe JR, SklarP,DalyMJ,O'DonovanMC,Craddock N, Sullivan PF, Smoller JW, Kendler KS,Wray NR (2013). Genetic relationship betweenfive psychiatricdisorders estimatedfrom genome-wide SNPs. Nature Genetics 45, 984-994.
66. Lewine R, Burbach D, Meltzer HY (1984). Effect of diagnostic criteria on the ratio of male to female schizophrenic patients. American Journal of Psychiatry 141, 84-87.
67. Lieberman JA, First MB (2007). Renaming schizophrenia. BMJ 334, 108.
68. Linscott RJ, Allardyce J, van Os J (2010). Seeking verisimilitude in a class: a systematic review of evidence that the criterial clinical symptoms of schizophrenia are taxonic. Schizophrenia Bulletin 36, 811-829.
69. Linscott RJ, van Os J (2013). An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: on the pathway from proneness to persistence to dimensional expression across mental disorders. Psychological Medicine 43, 1133-1149.
70. Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sorensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo Jr. B, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stuve O,Waubant E, Polman CH (2014). Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83, 278-286.
71. Mancuso SG, Morgan VA, Mitchell PB, Berk M, Young A, Castle DJ (2015). A comparison of schizophrenia, schizoaffective disorder, and bipolar disorder: results from the second Australian national psychosis survey. Journal of Affective Disorders 172, 30-37.
72. Maric N, Myin-Germeys I, Delespaul P, de Graaf R, Vollebergh W, Van Os J (2004). Is our concept of schizophrenia influenced by Berkson's bias? Social Psychiatry and Psychiatric Epidemiology 39, 600-605.
73. McAusland L, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J (2015). Anxiety in youth at clinical high risk for psychosis. Early Intervention in Psychiatry. In press. doi: 10.1111/eip.12274.
74. McGlashan TH (1988). A selective review of recent North American long-term followup studies of schizophrenia. Schizophrenia Bulletin 14, 515-542.
75. McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller TJ, Woods SW, Hawkins KA, Hoffman R, Lindborg S, Tohen M, Breier A (2003). The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophrenia Research 61, 7-18.
76. McGorry P, Nelson B (2016). Why we need a transdiagnostic staging approach to emerging psychopathology, early diagnosis, and treatment. JAMA Psychiatry 73, 191-192.
77. McGorry P, van Os J (2013). Redeeming diagnosis in psychiatry: timing versus specificity. Lancet 381, 343-345.
78. McGorry PD, Hamilton M, Goldstone S, Rickwood DJ (2016). Response to Jorm: headspace-A national and international innovation with lessons for redesign of mental health care in Australia. Australian and New Zealand Journal of Psychiatry 50, 9-10.
79. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, Germano D, Bravin J, McDonald T, Blair A, Adlard S, Jackson H (2002). Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry 59, 921-928.
80. McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D (2004). A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Medicine 2, 13.
81. McGrath JJ, Saha S, Al-Hamzawi A, Andrade L, Benjet C, Bromet EJ, Browne MO, Caldas de Almeida JM, Chiu WT, Demyttenaere K, Fayyad J, Florescu S, de Girolamo G, Gureje O, Haro JM, Ten Have M, Hu C, Kovess-Masfety V, Lim CC, Navarro-Mateu F, Sampson N, Posada-Villa J, Kendler KS, Kessler RC (2016). The bidirectional associations between psychotic experiences and DSM-IV mental disorders. American Journal of Psychiatry 173, 997-1006.
82. Milev P, Ho BC, Arndt S, Andreasen NC (2005). Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. American Journal of Psychiatry 162, 495-506.
83. Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J, McFarlane W, Perkins DO, Pearlson GD, Woods SW (2003). Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophrenia Bulletin 29, 703-715.
84. Moncrieff J, Middleton H (2015). Schizophrenia: a critical psychiatry perspective. Current Opinion in Psychiatry 28, 264-268.
85. Morrison AP, French P, Stewart SL, Birchwood M, Fowler D, Gumley AI, Jones PB, Bentall RP, Lewis SW, Murray GK, Patterson P, Brunet K, Conroy J, Parker S, Reilly T, Byrne R, Davies LM, Dunn G (2012). Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ 344, e2233.
86. Murray RM (1979). A reappraisal of American psychiatry. Lancet 1, 255-258.
87. Murray RM (2017). Mistakes I have made in my research career. Schizophrenia Bulletin 43, 253-256.
88. Murray RM, Sham P, Van Os J, Zanelli J, Cannon M, McDonald C (2004). A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophrenia Research 71, 405-416.
89. Nuevo R, Van Os J, Arango C, Chatterji S, Ayuso-Mateos JL (2013). Evidence for the early clinical relevance of hallucinatory-delusional states in the general population. Acta Psychiatrica Scandinavica 127, 482-493.
90. Perala J, Suvisaari J, Saarni SI, Kuoppasalmi K, Isometsa E, Pirkola S, Partonen T, Tuulio-Henriksson A, Hintikka J, Kieseppa T, Harkanen T, Koskinen S, Lonnqvist J (2007). Lifetime prevalence of psychotic and bipolar I disorders in a general population. Archives of General Psychiatry 64, 19-28.
91. Perlis RH, Uher R, Ostacher M, Goldberg JF, Trivedi MH, Rush AJ, Fava M (2011). Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. Archives of General Psychiatry 68, 351-360.
92. Poulton R, Caspi A,Moffitt TE, CannonM,Murray R, Harrington H (2000). Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study.Archives ofGeneral Psychiatry 57, 1053-1058.
93. Read J, Bentall RP (2012). Negative childhood experiences and mental health: theoretical, clinical and primary prevention implications. British Journal of Psychiatry 200, 89-91.
94. Reininghaus U, Bohnke JR, Hosang G, Farmer A, Burns T, McGuffin P, Bentall RP (2016). Evaluation of the validity and utility of a transdiagnostic psychosis dimension encompassing schizophrenia and bipolar disorder. British Journal of Psychiatry 209, 107-113.
95. Reininghaus U, Priebe S, Bentall RP (2013). Testing the psychopathology of psychosis: evidence for a general psychosis dimension. Schizophrenia Bulletin 39, 884-895.
96. Ritsner MS, Gottesman II (2011). The schizophrenia construct after 100 years of challenges. In Handbook of Schizophrenia Spectrum Disorders, Volume I: Conceptual Issues and Neurobiological Advances (ed. M. S. Ritsner), pp. 1-44. Springer: Dordrecht, The Netherlands.
97. Robins E, Guze SB (1970). Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. American Journal of Psychiatry 126, 983-987.
98. RosslerW, Riecher-Rossler A, Angst J, Murray R, Gamma A, Eich D, van Os J, Gross VA (2007). Psychotic experiences in the general population: a twenty-year prospective community study. Schizophrenia Research 92, 1-14.
99. Russo M, Levine SZ, Demjaha A, Di Forti M, Bonaccorso S, Fearon P, Dazzan P, Pariante CM, David AS, Morgan C, Murray RM, Reichenberg A (2014). Association between symptom dimensions and categorical diagnoses of psychosis: a cross-sectional and longitudinal investigation. Schizophrenia Bulletin 40, 111-119.
100. Saha S, Chant D, McGrath J (2007). A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Archives of General Psychiatry 64, 1123-1131.
101. Saha S, Chant D, McGrath J (2008). Meta-analyses of the incidence and prevalence of schizophrenia: conceptual and methodological issues. International Journal of Methods in Psychiatric Research 17, 55-61.
102. Saha S, Chant D, Welham J, McGrath J (2005). A systematic review of the prevalence of schizophrenia. PLoS Medicine 2, e141.
103. Saha S, Scott JG, Varghese D, McGrath JJ (2011). The association between general psychological distress and delusional-like experiences: a large population-based study. Schizophrenia Research 127, 246-251.
104. Sawa A, Snyder SH (2002). Schizophrenia: diverse approaches to a complex disease. Science 296, 692-695.
105. Sharifi V, Eaton WW, Wu LT, Roth KB, Burchett BM, Mojtabai R (2015). Psychotic experiences and risk of death in the general population: 24-27 year follow-up of the Epidemiologic Catchment Area study. British Journal of Psychiatry 207, 30-36.
106. Shevlin M, McElroy E, Bentall RP, Reininghaus U, Murphy J (2017). The psychosis continuum: testing a bifactor model of psychosis in a general population sample. Schizophrenia Bulletin 43, 133-141.
107. Smeets F, Lataster T, Dominguez MD, Hommes J, Lieb R, Wittchen HU, van Os J (2012). Evidence that onset of psychosis in the population reflects early hallucinatory experiences that through environmental risks and affective dysregulation become complicated by delusions. Schizophrenia Bulletin 38, 531-542.
108. Smeets F, Lataster T, van Winkel R, de Graaf R, Ten Have M, van Os J (2013). Testing the hypothesis that psychotic illness begins when subthreshold hallucinations combine with delusional ideation. Acta Psychiatrica Scandinavica 127, 34-47.
109. Spauwen J, Krabbendam L, Lieb R, Wittchen HU, van Os J (2004). Does urbanicity shift the population expression of psychosis? Journal of Psychiatric Research 38, 613-618.
110. Spauwen J, Krabbendam L, Lieb R, Wittchen HU, van Os J (2006a). Evidence that the outcome of developmental expression of psychosis is worse for adolescents growing up in an urban environment. Psychological Medicine 36, 407-415.
111. Spauwen J, Krabbendam L, Lieb R, Wittchen HU, van Os J (2006b). Impact of psychological trauma on the development of psychotic symptoms: relationship with psychosis proneness. British Journal of Psychiatry 188, 527-533.
112. Strauss JS, Gift TE (1977). Choosing an approach for diagnosing schizophrenia. Archives of General Psychiatry 34, 1248-1253.
113. Sullivan G, Mittal D, Reaves CM, Haynes TF, Han X, Mukherjee S, Morris S, Marsh L, Corrigan PW (2015). Influence of schizophrenia diagnosis on providers' practice decisions. Journal of Clinical Psychiatry 76, 1068-1074; quiz 1074.
114. Takahashi H, Ideno T, Okubo S, Matsui H, Takemura K, Matsuura M, Kato M, Okubo Y (2009). Impact of changing the Japanese term for 'schizophrenia' for reasons of stereotypical beliefs of schizophrenia in Japanese youth. Schizophrenia Research 112, 149-152.
115. Tamminga CA, Ivleva EI, Keshavan MS, Pearlson GD, Clementz BA, Witte B, Morris DW, Bishop J, Thaker GK, Sweeney JA (2013). Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Networkon Intermediate Phenotypes (B-SNIP). American Journal of Psychiatry 170, 1263-1274.
116. Thomas L (1973). Notes of a biology-watcher. Living language. New England Journal of Medicine 289, 1298-1300.
117. Thompson A, Singh S, Birchwood M (2016). Views of early psychosis clinicians on discontinuation of antipsychotic medication following symptom remission in first episode psychosis. Early Intervention in Psychiatry 10, 355-361.
118. Tighe SK, Mahon PB, Potash JB (2011). Predictors of lithium response in bipolar disorder. Therapeutic Advances in Chronic Disease 2, 209-226.
119. van Os J (2009). A salience dysregulation syndrome. British Journal of Psychiatry 194, 101-103.
120. van Os J (2013). The dynamics of subthreshold psychopathology: implications for diagnosis and treatment. American Journal of Psychiatry 170, 695-698.
121. van Os J (2016). 'Schizophrenia' does not exist. BMJ 352, i375.
122. Van Os J, Delespaul P (2005). Toward a world consensus on prevention of schizophrenia. Dialogues in Clinical Neuroscience 7, 53-67.
123. van Os J, Gilvarry C, Bale R, van Horn E, Tattan T, White I, Murray R (2000). Diagnostic value of the DSM and ICD categories of psychosis: an evidence-based approach. UK700 Group. Social Psychiatry and Psychiatric Epidemiology 35, 305-311.
124. Van Os J, Guloksuz S (2017). A critique of the 'ultra-high risk' and 'transition' paradigm. World Psychiatry 16, 200-206.
125. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L (2009). A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychological Medicine 39, 179-195.
126. van Os J, Reininghaus U (2016). Psychosis as a transdiagnostic and extended phenotype in the general population. World Psychiatry 15, 118-124.
127. van Os J, van der Steen Y, Islam MA, Guloksuz S, Rutten BP, Simons CJ, Investigators G (2017). Evidence that polygenic risk for psychotic disorder is expressed in the domain of neurodevelopment, emotion regulation and attribution of salience. Psychological Medicine 1-17. In press. doi: 10.1017/S0033291717000915.
128. van Os J, Wright P, Murray R (1997). Follow-up studies of schizophrenia I: natural history and non-psychopathological predictors of outcome. European Psychiatry 12(Suppl 5), 327s-341s.
129. van Rossum I, Dominguez MD, Lieb R, Wittchen HU, van Os J (2011). Affective dysregulation and reality distortion: a 10-year prospective study of their association and clinical relevance. Schizophrenia Bulletin 37, 561-571.
130. Van Snellenberg JX, de Candia T (2009). Meta-analytic evidence for familial coaggregation of schizophrenia andbipolar disorder. Archives ofGeneralPsychiatry 66, 748-755.
131. Ventura J, Hellemann GS, Thames AD, Koellner V, Nuechterlein KH (2009). Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis. Schizophrenia Research 113, 189-199.
132. Waddington JL, Scully PJ, Youssef HA (1997). Developmental trajectory and disease progression in schizophrenia: the conundrum, and insights from a 12-year prospective study in the Monaghan 101. Schizophrenia Research 23, 107-118.
133. Werbeloff N, Drukker M, Dohrenwend BP, Levav I, Yoffe R, van Os J, Davidson M, Weiser M (2012). Self-reported attenuated psychotic symptoms as forerunners of severe mental disorders later in life. Archives of General Psychiatry 69, 467-475.
134. Wigman JT, Lin A, Vollebergh WA, van Os J, Raaijmakers QA, Nelson B, Baksheev G, Yung AR (2011). Subclinical psychosis and depression: co-occurring phenomena that do not predict each other over time. Schizophrenia Research 130, 277-281.
135. Wigman JT, van Nierop M, Vollebergh WA, Lieb R, Beesdo-Baum K, Wittchen HU, van Os J (2012). Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity-implications for diagnosis and ultra-high risk research. Schizophrenia Bulletin 38, 247-257.
136. Wigman JT, van Os J, Abidi L, Huibers MJ, Roelofs J, Arntz A, Kelleher I, Peeters FP (2014). Subclinical psychotic experiences and bipolar spectrum features in depression: association with outcome of psychotherapy. Psychological Medicine 44, 325-336.
137. Woodberry KA, Seidman LJ, Bryant C, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Mathalon DH, Perkins DO, Tsuang MT, Walker EF, Woods SW (2016). Treatment precedes positive symptoms in North American adolescent and young adult clinical high risk cohort. Journal of Clinical Child and Adolescent Psychology 1-10. In press. doi:10.1080/ 15374416.2016.1212361.
138. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, Francey SM, Cosgrave EM, Killackey E, Stanford C, Godfrey K, Buckby J (2005). Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Australian and New Zealand Journal of Psychiatry 39, 964-971.
139. Zipursky RB, Reilly TJ, Murray RM (2013). The myth of schizophrenia as a progressive brain disease. Schizophrenia Bulletin 39, 1363-1372.